REFERENCES
- Lawn SD, Zumla AI. Tuberculosis. Lancet. 2011;378:57–72.
- WHO. Global Tuberculosis Report 2013. Geneva: World Health Organization; 2013. Available at: http://apps.who.int/iris/bitstream/10665/91355/1/9789241564656_eng.pdf. Accessed July 16, 2015.
- Zwerling A, Behr MA, Verma A, et al. The BCG World Atlas: A database of global BCG vaccination policies and practices. PLoS Med. 2011;8: e1001012.
- Menzies D. What does tuberculin reactivity after bacille Calmette-Guérin vaccination tell us? Clin Infect Dis. 2000;31(Suppl 3):S71–S74.
- Gupta V, Gupta A, Rao NA. Intraocular tuberculosis – an update. Surv Ophthalmol. 2007;52:561–587.
- Liberman P, Gauro F, Berger O, et al. Causes of uveitis in a tertiary center in Chile: a cross-sectional retrospective review. Ocul Immunol Inflamm. 2014;1–7.
- Bodaghi B, LeHoang P. Ocular tuberculosis. Curr Opin Ophthalmol. 2000;11:443–448.
- Bansal R, Gupta A, Gupta V, et al. Role of anti-tubercular therapy in uveitis with latent/manifest tuberculosis. Am J Ophthalmol. 2008;146:772–779.
- Lou SM, Larkin KL, Winthrop K, et al.; members of Uveitis Specialists Study Group. Lack of consensus in the diagnosis and treatment for ocular tuberculosis among uveitis specialists. Ocul Immunol Inflamm. 2014; 1–7.
- Lalvani A, Pareek M. Interferon gamma release assays: principles and practice. Enfermedades Infecc Microbiol Clínica. 2010;28:245–252.
- Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509–516.
- Tabbara KF. Tuberculosis. Curr Opin Ophthalmol. 2007;18:493–501.
- Gupta A, Sharma A, Bansal R, et al. Classification of intraocular tuberculosis. Ocul Immunol Inflamm. 2015;23:7–13.
- Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647–652.
- International Study Group for Behçet’s Disease. Criteria for diagnosis of Behçet’s disease. Lancet. 1990;335:1078–1080.
- Ang M, Wong WL, Li X, et al. Interferon γ release assay for the diagnosis of uveitis associated with tuberculosis: a Bayesian evaluation in the absence of a gold standard. Br J Ophthalmol. 2013;97:1062–1067.
- Wroblewski KJ, Hidayat AA, Neafie RC, et al. Ocular tuberculosis: a clinicopathologic and molecular study. Ophthalmology. 2011;118:772–777.
- Ang M, Wong W, Ngan CCL, et al. Interferon-gamma release assay as a diagnostic test for tuberculosis-associated uveitis. Eye Lond Engl. 2012;26:658–665.
- Wang L, Turner MO, Elwood RK, et al. A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements. Thorax. 2002;57:804–809.
- La Distia Nora R, van Velthoven MEJ, Ten Dam-van Loon NH, et al. Clinical manifestations of patients with intraocular inflammation and positive QuantiFERON-TB gold in-tube test in a country nonendemic for tuberculosis. Am J Ophthalmol. 2014;157:754–761.
- Llorenç V, González-Martin J, Keller J, et al. Indirect supportive evidence for diagnosis of tuberculosis-related uveitis: from the tuberculin skin test to the new interferon gamma release assays. Acta Ophthalmol (Copenh)</i>. 2013;91:e99–107.
- Leyten EMS, Prins C, Bossink AWJ, et al. Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-gamma assay. Eur Respir J. 2007;29:1212–1216.
- Naseer A, Naqvi S, Kampmann B. Evidence for boosting Mycobacterium tuberculosis-specific IFN-γ responses at 6 weeks following tuberculin skin testing. Eur Respir J. 2007;29:1282–1283.
- Richeldi L, Ewer K, Losi M, et al. Repeated tuberculin testing does not induce false positive ELISPOT results. Thorax. 2006;61:180.